BUSINESS WIRE)--Abviva, Inc. is a publicly traded biomedical company established to develop and commercialize diagnostic and therapeutic products from a protein discovered by cancer research scientists at the prestigious University of Michigan Cancer Center. The scientists discovered a secreted protein produced in breast epithelial cells that inhibits the growth of breast cancer.